Navigation Links
North American Spine Welcomes Robert R. Bulger, M.D. to Dallas Physician Group
Date:8/16/2010

DALLAS, Aug. 16 /PRNewswire/ -- North American Spine is pleased to announce that Robert R. Bulger, M.D. has joined our group to help further the advancement of minimally invasive back pain treatment techniques.  The AccuraScope™ Discectomy and Neural Decompression (D.N.D.) procedure treats a variety of conditions responsible for back pain on multiple lumbar levels using one single, tiny incision. North American Spine's trained physicians are the only doctors performing the procedure in the Dallas/Fort Worth area. North American Spine plans to expand its elite group of hand-selected specialists in key locations nationwide, including Houston, TX soon, with expansion to select markets worldwide also under way.

After attending the prestigious Mayo Medical School College of Medicine, Dr. Bulger trained in both Internal Medicine and Anesthesiology at Emory University in Atlanta.  During his fellowship at Penn State, he developed epidural infusion protocols and techniques for post-operative pain that have since been adopted by numerous hospitals, including the world-renowned Cleveland Clinic.  Other honors include an invitation to be an expert panelist and lecturer at the American Society of Anesthesiology national meeting, visiting professor for the UT Southwestern Medical Center residency and a former President of the Dallas County Anesthesia Society.  Dr. Bulger has also been selected by his peers as one of D Magazine's Best Doctors in Dallas in each of the past six years.

"North American Spine and our specially trained physicians are dedicated to providing the best spine care for patients," said Sam Bailey, Ph.D., President of North American Spine. "We are excited and honored to work with a physician of Dr. Bulger's stature.  His knowledge and experience will help us continue to improve our already excellent outcomes and formalize our research studies for peer-reviewed publication."

Dr. Bulger is specially trained on the AccuraScope™ procedure which allows physicians to examine the inside of the spinal canal and the discs of the lower back to identify, diagnose and treat any tears, ruptures, herniations, bulges or other abnormalities -- many of which may be undetected or mis-identified by MRIs.

"The AccuraScope™ procedure represents a significant, yet natural evolution of proven pain management techniques," said Dr. Bulger, physician with North American Spine. "This represents the logical next step in a conservative course of treatments if the patient does not respond to traditional pain management techniques."

The AccuraScope™ procedure is a minimally invasive, natural opening procedure that allows doctors to diagnose and treat acute and chronic back pain problems. AccuraScope™ has a demonstrated track record and an unrivaled success rate with more than 5,000 patients already treated.

For more information on Dr. Bulger and North American Spine's minimally invasive procedures, please visit www.northamericanspine.com.

About North American Spine

North American Spine's revolutionary AccuraScope™ Discectomy and Neural Decompression (D.N.D.) procedure is a minimally invasive, natural opening procedure used to both diagnose and treat disc problems on multiple levels directly at their source. The procedure takes approximately 30-45 minutes with patients usually being discharged in about an hour and able to resume light physical activity the next day. It has a demonstrated track record and an unrivaled success rate with more than 5,000 patients already treated for chronic and acute back pain. North American Spine is the only group in the Dallas/Fort Worth area that performs the AccuraScope™ D.N.D. procedure and has trained physicians dedicated to providing the best spine care for patients. For more information about the AccuraScope™ D.N.D. procedure and North American Spine, please visit www.northamericanspine.com.


'/>"/>
SOURCE North American Spine
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
2. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
3. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
4. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
5. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
6. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
7. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
8. Northwestern Memorial Transplant Program Initiates New Study
9. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
10. Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients
11. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016 ... hydroxyurea (HU) in Complete Hematologic Response (CHR) ... ropeginterferon alfa-2b versus HU AOP will submit ... CONTINUATION-PV to obtain European marketing authorization in the coming months ... the FDA as it seeks approval for commercialization in the ...
(Date:12/4/2016)... 2016 Sickle cell disease (SCD) is an ... cells that get stuck in veins and block blood ... and complications leading to death. Each year, approximately 300,000 ... most of them lack access to comprehensive care or ... therapy for SCD, a pill called hydroxyurea approved more ...
(Date:12/2/2016)... SILVER SPRING, Md. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... a new indication for Jardiance (empagliflozin) to reduce the ... 2 diabetes mellitus and cardiovascular disease. ... adults with type 2 diabetes mellitus," said Jean-Marc ... Metabolism and Endocrinology Products in FDA,s Center for Drug ...
Breaking Medicine Technology:
(Date:12/4/2016)... , ... December 04, 2016 , ... ... major cosmetic surgery can now take advantage of a cosmetic procedure known as ... rejuvenation treatment that reduces the appearance of age spots, fine lines, uneven ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges ... brush properly to achieve optimal results. This important necessity inspired an inventor from Las ... a way to ensure that people break or avoid bad techniques of brushing the ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will host ... honoring the 2016 MPN Heroes—eight individuals who have made a difference in the field ... the standard of care, demonstrating leadership within the MPN community and/or a commitment to ...
(Date:12/2/2016)... Dothan, AL (PRWEB) , ... December 02, 2016 ... ... leaders from across the Dothan-Wiregrass Area in Alabama are expected to attend the ... Mike Schmitz, will help provide scholarship funds for area students and operating support ...
Breaking Medicine News(10 mins):